Analyst Forecast. According to 4 analysts, the average rating for SGMO stock is "Buy." The month stock price forecast is $, which is an increase of. Sangamo Therapeutics (SGMO) stock price prediction is USD. The Sangamo Therapeutics stock forecast is USD for August The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. The 3 analysts with month price forecasts for SGMO stock have an average target of , with a low estimate of and a high estimate of The average. Is Sangamo BioSciences stock A Buy? Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a.
Sangamo Therapeutics, inc (SGMO) Q3 Earnings Call Transcript. SGMO earnings call for the period ending October 3, Motley Fool Transcribers. Based on short-term price targets offered by five analysts, the average price target for Sangamo Therapeutics comes to $ The forecasts range from a low of. The 23 analysts offering price forecasts for Sangamo Therapeutics have a median target of , with a high estimate of and a low estimate of The. Get Sangamo Therapeutics Inc (SGMO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Track Sangamo Therapeutics Inc (SGMO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Sangamo Therapeutics (NASDAQ:SGMO) Stock, Analyst Ratings, Price Targets, Forecasts Sangamo Therapeutics Inc has a consensus price target of $ based on. The average price target is $ with a high estimate of $5 and a low estimate of $1. Sign in to your SmartPortfolio to see more analyst recommendations. Discover Sangamo Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. Analyst's Opinion. Consensus Rating. Sangamo Therapeutics has received a consensus rating of Hold. The company's average rating score is , and is based on 1. Sangamo Biosciences (SGMO) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Sangamo Therapeutics First Quarter Earnings: US$ loss per share (vs US$ profit in 1Q ). Sangamo Therapeutics (NASDAQ:SGMO) First Quarter
SGMO Stock Overview · Trading at % below our estimate of its fair value · Revenue is forecast to grow % per year · Has less than 1 year of cash runway. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Just Reported And Analysts Have Been Lifting Their Price Targets. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the last. Find the latest Sangamo Therapeutics Inc (SGMO) stock forecast, month price target, predictions and analyst recommendations. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. SGMO will report earnings. Analysts average stock forecasts to be materialized ratio is % with an average time for these price targets to be met of days. Highest price target. View Sangamo Therapeutics, Inc. SGMO stock quote prices, financial information, real-time forecasts, and company news from CNN. The average one-year price target for Sangamo Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price. On average, Wall Street analysts predict that Sangamo Therapeutics's share price could reach $ by Aug 22, The average Sangamo Therapeutics stock price.
See the latest Sangamo Therapeutics Inc stock price (SGMO:XNAS), related news, valuation, dividends and more to help you make your investing decisions. According to analysts, SGMO price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $ last updated August 23, at PM EDT. Q. Does Sangamo Therapeutics (SGMO) pay a. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a. According to the 4 analysts' twelve-month price targets for Sangamo Therapeutics, the average price target is $ The highest price target for SGMO is $
Over the last 12 months, its price fell by percent. Looking ahead, we forecast Sangamo BioSciences to be priced at by the end of this quarter and at. Sangamo Therapeutics SGMO share price forecast & targets for short-term is a downtrend, and nearest possible share price target is · Sangamo Therapeutics. Following the release of the earnings report, SGMO's price increased to $ on Aug 7, , recording a % price change in the hour period. Report. Is Sangamo Therapeutics Stock Undervalued? The current Sangamo Therapeutics [SGMO] share price is $ The Score for SGMO is 61, which is 22% above its. Tomorrow's movement Prediction of Sangamo Therapeutics, Inc. SGMO appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally. Stock SGMO SANGAMO THERAPEUTICS, INC. PDF Report. Consensus Sangamo Therapeutics, Inc. Equities. SGMO. US Market Closed - Nasdaq. Other stock markets. What is the Sangamo Therapeutics stock price / share price today? The Sangamo Therapeutics stock price is USD today. Will SGMO stock price drop / fall?